Cargando…
Zwitterionic chitosan for the systemic treatment of sepsis
Severe sepsis and septic shock are life-threatening conditions, with Gram-negative organisms responsible for most sepsis mortality. Systemic administration of compounds that block the action of lipopolysaccharide (LPS), a constituent of the Gram-negative outer cell membrane, is hampered by their hyd...
Autores principales: | Cho, Eun Jung, Doh, Kyung-Oh, Park, Jinho, Hyun, Hyesun, Wilson, Erin M., Snyder, Paul W., Tsifansky, Michael D., Yeo, Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944199/ https://www.ncbi.nlm.nih.gov/pubmed/27412050 http://dx.doi.org/10.1038/srep29739 |
Ejemplares similares
-
Zwitterionic Chitosan Derivative, a New Biocompatible Pharmaceutical Excipient, Prevents Endotoxin-Mediated Cytokine Release
por: Bajaj, Gaurav, et al.
Publicado: (2012) -
Spreading of Cell Aggregates on Zwitterion-Modified
Chitosan Films
por: Qi, Baowen, et al.
Publicado: (2018) -
Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis
por: Yuk, Simseok A., et al.
Publicado: (2021) -
Cell Nucleus-Targeting Zwitterionic Carbon Dots
por: Jung, Yun Kyung, et al.
Publicado: (2015) -
Tumor Targeting with Methotrexate-Conjugated Zwitterionic Near-Infrared Fluorophore for Precise Photothermal Therapy
por: Jo, Gayoung, et al.
Publicado: (2022)